Site icon Ortho Songbad English

Silco Pharma reveals Q1 Financials

silco pharmceuticals

One of the listed companies, Silco Pharmaceutiacals Limited discloses its financial reports for the first quarter, (July-September 23).

The company’s earnings per share (EPS) of Tk 0.11 paisa in Q1 of the current financial year (July-September 23). EPS of Tk 0.29 paisa during the same period last year. NAV per share was Tk. 22.52 as of September 30, 2023.

Share this
Exit mobile version